Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness of Rituximab in Pediatric OMS Patients.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- Status
- WITHDRAWN
- Phase
- PHASE2
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
- Status
- UNKNOWN
- Phase
- PHASE3
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
- Status
- UNKNOWN
- Phase
- PHASE3
Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2